{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:26:39Z","timestamp":1759623999514,"version":"build-2065373602"},"reference-count":47,"publisher":"BMFH Press","issue":"4","funder":[{"name":"Research and Community Services (Lembaga Penelitian dan Pengabdian Masyarakat, LPPM) of Hasanuddin University","award":["02993\/UN4.22\/PT.01.03\/2024"],"award-info":[{"award-number":["02993\/UN4.22\/PT.01.03\/2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.12938\/bmfh.2024-131","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:06:21Z","timestamp":1750701981000},"page":"290-297","source":"Crossref","is-referenced-by-count":0,"title":["Beneficial effects of probiotic supplementation (<i>Lactiplantibacillus plantarum<\/i> Dad-13) on body weight, liver function, and liver histopathological features in non-alcoholic fatty liver disease (NAFLD) model Sprague-Dawley rats"],"prefix":"10.12938","volume":"44","author":[{"given":"Rahmawati","family":"MINHAJAT","sequence":"first","affiliation":[{"name":"Biomedical Sciences, Postgraduate School, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"},{"name":"Department of Histology, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"},{"name":"Department of Internal Medicine, Faculty of Medicine, Hasanuddin University Hospital, Jl. Perintis Kemerdekaan 11, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"AFIFAH","sequence":"additional","affiliation":[{"name":"Biomedical Sciences, Postgraduate School, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husni","family":"CANGARA","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"MUIS","sequence":"additional","affiliation":[{"name":"Department of Histology, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agussalim","family":"BUKHARI","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition, Faculty of Medicine, Hasanuddin University Hospital, Jl. Perintis Kemerdekaan 11, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitti","family":"WAHYUNI","sequence":"additional","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan 10, Tamalanrea, Makassar 90245, Indonesia"},{"name":"Hasanuddin University Medical Research Center, Hasanuddin University Hospital, Jl. Perintis Kemerdekaan 11, Tamalanrea, Makassar 90245, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67: 328\u2013357.","DOI":"10.1002\/hep.29367"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD. 2023. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29 Suppl: S32\u2013S42.","DOI":"10.3350\/cmh.2022.0365"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. 2022. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 7: 851\u2013861.","DOI":"10.1016\/S2468-1253(22)00165-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. 2019. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 4: 389\u2013398.","DOI":"10.1016\/S2468-1253(19)30039-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wu Y, Zheng Q, Zou B, Yeo YH, Li X, Li J, Xie X, Feng Y, Stave CD, Zhu Q, et al. 2020. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 14: 259\u2013269.","DOI":"10.1007\/s12072-020-10023-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chan WK. 2023. Comparison between obese and non-obese nonalcoholic fatty liver disease. Clin Mol Hepatol 29 Suppl: S58\u2013S67.","DOI":"10.3350\/cmh.2022.0350"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. 2018. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15: 11\u201320.","DOI":"10.1038\/nrgastro.2017.109"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dyson JK, Anstee QM, McPherson S. 2014. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 5: 211\u2013218.","DOI":"10.1136\/flgastro-2013-100403"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhao Z, Chen L, Zhao Y, Wang C, Duan C, Yang G, Niu C, Li S. 2020. Lactobacillus plantarum<\/i> NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Appl Microbiol Biotechnol 104: 5273\u20135282.","DOI":"10.1007\/s00253-020-10633-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Guo X, Yin X, Liu Z, Wang J. 2022. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci 23: 15489.","DOI":"10.3390\/ijms232415489"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jasirwan COM, Lesmana CRA, Hasan I, Sulaiman AS, Gani RA. 2019. The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Biosci Microbiota Food Health 38: 81\u201388.","DOI":"10.12938\/bmfh.18-032"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Buzzetti E, Pinzani M, Tsochatzis EA. 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65: 1038\u20131048.","DOI":"10.1016\/j.metabol.2015.12.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Abdul-Hai A, Abdallah A, Malnick SD. 2015. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 7: 1679\u20131684.","DOI":"10.4254\/wjh.v7.i12.1679"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. 2021. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates. Int J Biol Sci 17: 818\u2013833.","DOI":"10.7150\/ijbs.56214"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, et al. 2017. Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World J Gastroenterol 23: 712\u2013722.","DOI":"10.3748\/wjg.v23.i4.712"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, et al. MAESTRO-NASH Investigators 2024. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 390: 497\u2013509.","DOI":"10.1056\/NEJMoa2309000"},{"key":"17","unstructured":"17. Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H. 2013. Probiotics and nonalcoholic fatty liver disease. Middle East J Dig Dis 5: 129\u2013136."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Eng JM, Estall JL. 2021. Diet-induced models of non-alcoholic fatty liver disease: food for thought on sugar, fat, and cholesterol. Cells 10: 1805.","DOI":"10.3390\/cells10071805"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rahayu ES. 2021. Erratum: Effect of probiotic Lactobacillus plantarum<\/i> Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol 27: 6511\u20136512.","DOI":"10.3748\/wjg.v27.i38.6511"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ishii Y, Blundell JE, Halford JCG, Rodgers RJ. 2003. Palatability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 80: 37\u201347.","DOI":"10.1016\/S0031-9384(03)00207-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Aimaretti E, Chimienti G, Rubeo C, Di Lorenzo R, Trisolini L, Dal Bello F, Moradi A, Collino M, Lezza AMS, Aragno M, et al. 2023. Different effects of high-fat\/high-sucrose and high-fructose diets on advanced glycation end-product accumulation and on mitochondrial involvement in heart and skeletal muscle in mice. Nutrients 15: 4874.","DOI":"10.3390\/nu15234874"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Serino M, Luche E, Gres S, Baylac A, Berg\u00e9 M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, et al. 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543\u2013553.","DOI":"10.1136\/gutjnl-2011-301012"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Zhao Y, Wang QY, Zeng LT, Wang JJ, Liu Z, Fan GQ, Li J, Cai JP. 2022. Long-term high-fat high-fructose diet induces type 2 diabetes in rats through oxidative stress. Nutrients 14: 2181.","DOI":"10.3390\/nu14112181"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Horne RG, Yu Y, Zhang R, Abdalqadir N, Rossi L, Surette M, Sherman PM, Adeli K. 2020. High fat-high fructose diet-induced changes in the gut microbiota associated with dyslipidemia in Syrian hamsters. Nutrients 12: 3557.","DOI":"10.3390\/nu12113557"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jarukamjorn K, Jearapong N, Pimson C, Chatuphonprasert W. 2016. A high-fat, high-fructose diet induces antioxidant imbalance and increases the risk and progression of nonalcoholic fatty liver disease in mice. Scientifica (Cairo) 2016: 5029414.","DOI":"10.1155\/2016\/5029414"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Leung C, Rivera L, Furness JB, Angus PW. 2016. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 13: 412\u2013425.","DOI":"10.1038\/nrgastro.2016.85"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhao Z, Wang C, Zhang L, Zhao Y, Duan C, Zhang X, Gao L, Li S. 2019. Lactobacillus plantarum<\/i> NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK\/Nrf2 pathway. Appl Microbiol Biotechnol 103: 5843\u20135850.","DOI":"10.1007\/s00253-019-09703-4"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bajaj JS, Khoruts A. 2020. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. J Hepatol 72: 1003\u20131027.","DOI":"10.1016\/j.jhep.2020.01.017"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mouzaki M, Loomba R. 2019. Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention. Therap Adv Gastroenterol 12: 1756284819858470.","DOI":"10.1177\/1756284819858470"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Staltner R, Burger K, Baumann A, Bergheim I. 2023. Fructose: a modulator of intestinal barrier function and hepatic health? Eur J Nutr 62: 3113\u20133124.","DOI":"10.1007\/s00394-023-03232-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chuaypen N, Asumpinawong A, Sawangsri P, Khamjerm J, Iadsee N, Jinato T, Sutheeworapong S, Udomsawaengsup S, Tangkijvanich P. 2024. Gut microbiota in patients with non-alcoholic fatty liver disease without type 2 diabetes: stratified by body mass index. Int J Mol Sci 25: 1807.","DOI":"10.3390\/ijms25031807"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Maghfirotin Marta B, Tyas U, Muhammad Nur C, Jaka W, Endang Sutriswati R. 2019. Effects of consumption of probiotic powder containing Lactobacillus plantarum<\/i> Dad-13 on fecal bacterial population in school-age children in Indonesia. Int J Probiotics Prebiotics 14: 1\u20138.","DOI":"10.37290\/ijpp2641-7197.14:1-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107: 14691\u201314696.","DOI":"10.1073\/pnas.1005963107"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Delzenne NM, Cani PD. 2011. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31: 15\u201331.","DOI":"10.1146\/annurev-nutr-072610-145146"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Choi WJ, Dong HJ, Jeong HU, Ryu DW, Song SM, Kim YR, Jung HH, Kim TH, Kim YH. 2020. Lactobacillus plantarum<\/i> LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes. Sci Rep 10: 869.","DOI":"10.1038\/s41598-020-57615-5"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. 2014. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol 221: T1\u2013T16.","DOI":"10.1530\/JOE-13-0414"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Zhang Z, Liang X, Lv Y, Yi H, Chen Y, Bai L, Zhou H, Liu T, Li R, Zhang L. 2020. Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro. J Funct Foods 64: 103664.","DOI":"10.1016\/j.jff.2019.103664"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A. 2019. Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 25: 4814\u20134834.","DOI":"10.3748\/wjg.v25.i33.4814"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Park M, Park EJ, Kim SH, Lee HJ. 2021. Lactobacillus plantarum<\/i> ATG-K2 and ATG-K6 ameliorates high-fat with high-fructose induced intestinal inflammation. Int J Mol Sci 22: 4444.","DOI":"10.3390\/ijms22094444"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Oren R. 2014. Serum liver enzymes\u2014should we count on them? Liver Int 34: 171\u2013173.","DOI":"10.1111\/liv.12366"},{"key":"41","unstructured":"41. Aguwa U, Owoeye O, Olu SI, Ukoba O. 2016. Eratogenic effect of maternal vitamin a consumption on the liver, limbs and other morphological parameters of the pups of Wistar rats. Int J Basic Applied Innovative Res 5: 130\u2013137."},{"key":"42","unstructured":"42. Grzegorz WT. 2018. Jaundice. In<\/i>: Kliegman RM, Lye PS, Bordini BJ (eds), Nelson pediatric symptom-based diagnosis: common diseases and their mimics. Philadelphia: Elsevier, pp. 255\u2013256."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Bergheim I, Weber S, Vos M, Kr\u00e4mer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. 2008. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48: 983\u2013992.","DOI":"10.1016\/j.jhep.2008.01.035"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kuchay MS, Mart\u00ednez-Montoro JI, Choudhary NS, Fern\u00e1ndez-Garc\u00eda JC, Ramos-Molina B. 2021. Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges. Biomedicines 9: 1346.","DOI":"10.3390\/biomedicines9101346"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Hasan AU, Rahman A, Kobori H. 2019. Interactions between host PPARs and gut microbiota in health and disease. Int J Mol Sci 20: 387.","DOI":"10.3390\/ijms20020387"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Mei L, Tang Y, Li M, Yang P, Liu Z, Yuan J, Zheng P. 2015. Co-administration of cholesterol-lowering probiotics and anthraquinone from Cassia obtusifolia L. Ameliorate non-alcoholic fatty liver. PLoS One 10: e0138078.","DOI":"10.1371\/journal.pone.0138078"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Arellano-Garc\u00eda L, Portillo MP, Mart\u00ednez JA, Milton-Laskibar I. 2022. Usefulness of probiotics in the management of NAFLD: evidence and involved mechanisms of action from preclinical and human models. Int J Mol Sci 23: 3167.","DOI":"10.3390\/ijms23063167"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/4\/44_2024-131\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:38:43Z","timestamp":1759552723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/44\/4\/44_2024-131\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2024-131","relation":{},"ISSN":["2186-3342"],"issn-type":[{"type":"electronic","value":"2186-3342"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024-131"}}